Bone Tumor

骨肿瘤
  • 文章类型: Case Reports
    浆细胞瘤形成后,骨肉瘤是最常见的原发性骨肿瘤,占所有肉瘤的20%。恶性肿瘤的特征在于由肿瘤细胞形成骨或类骨质。长骨是最常见的受累部位。在颌骨中,约5%的参与,每年150万人中有1人的发病率。它在广泛的年龄范围内发展,但在第三和第四个十年中更为常见,在下颌骨中比在上颌骨中略多。在这个案例报告中,一名24岁的男性患者在过去1周内报告了在第三磨牙拔除后出现的左下颌骨肿块。在正像图中,注意到硬膜层的丢失和小梁图案的变化。组织病理学发现提示成骨细胞成骨肉瘤。该患者接受了半颌骨切除术,然后进行化疗。该病例报告的主要目的是根据临床和影像学检查重点介绍早期诊断该肿瘤的重要性。特别是考虑到这种肿瘤的快速进展和侵袭性。
    After plasma cell neoplasia, osteosarcoma is the most common primary bone tumor which accounts for 20% of all sarcomas. A malignant tumor is characterized by the formation of bone or osteoid by tumor cells. Long bones are the most common site of involvement. In the jaw bones, approximately 5% of involvement with an incidence of 1 in 1.5 million persons per year. It develops in a broad range of ages but is more common in the third and fourth decades, slightly more often in the mandible than in the maxilla. In this case report, a 24-year-old male patient reported a mass in the left mandible for the past 1 week which appeared after the third molar extraction. In the orthopantomogram, a loss of lamina dura and a change in the trabecular pattern was noted. Histopathological findings were suggestive of osteoblastic osteogenic sarcoma. The patient underwent a hemi-mandibulectomy followed by chemotherapy. The main aim of this case report was to focus on the importance of early diagnosis of this tumor based on clinical and radiographic examinations, particularly taking into account the fast progression and aggressiveness of this neoplasm.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:在过去的几十年里,肿瘤关节成形术已发展成为解决四肢肿瘤切除后骨缺损的既定治疗方法。由于诊断对患者的生活有重大影响,对功能恢复给出明确的预期是很重要的。因此,我们调查了髋关节恶性肿瘤肿瘤关节置换术后的功能结局和生活质量(QoL).
    方法:这项回顾性研究包括2010年至2018年期间连续进行模块化髋关节置换术的恶性髋关节肿瘤切除患者。人口统计,肿瘤实体,通过分析医疗记录和围手术期记录,评估了肿瘤和治疗的并发症。使用以下患者报告的结局指标(PROM)进行功能结局评估:Harris髋关节评分(HHS),肌肉骨骼肿瘤协会评分(MSTS),和简短表格调查36(SF-36)。此外,我们在两组中进行了亚组分析:一组分为幸存者和非幸存者,以及年轻人(<57岁)和老年人(>57岁)。
    结果:本研究共纳入30例患者。在后续行动时,19名患者死亡。平均随访时间为3.2(±2.51)年。手术时的平均年龄为60.3(±15.20)岁。值得注意的是,没有截肢病例报告(0%).发现植入物失败5例(16.67%)。其中,一个归因于感染(3.3%),无菌性松动导致4例(13.3%)。就功能结果而言,MSTS显示良好的结果(18±7;范围:7-28;60%),HHS显示中等结局(75.3%).年轻的幸存者(<57岁)在SF-36中的MSTS和身体功能方面表现出明显的优异结果(p=0.03)。
    结论:总之,本研究显示肿瘤关节置换相关并发症减少,功能结局和QoL均令人满意.值得注意的方面包括截肢和局部肿瘤复发率相对较低,这显著有利于选择合适的治疗方案。此外,研究结果强调了患者年龄对整体功能和日常活动参与度的重大影响.
    BACKGROUND: Over the past few decades, tumor arthroplasty has evolved into an established therapeutic approach for addressing bone defects following tumor resection in the extremities. As the diagnosis has a significant impact on patients\' lives, it is important to give clear expectations for functional recovery. Therefore, we investigated both the functional outcomes and the quality of life (QoL) after tumor arthroplasty for malignant hip tumors.
    METHODS: This retrospective study included patients who had undergone resections of malignant hip tumors with consecutive modular hip arthroplasty between 2010 and 2018. Demographics, tumor entity, and complications stemming from both tumors and treatments were evaluated through the analysis of medical records and perioperative records. The assessment of functional outcomes was conducted with the following patient-reported outcome measures (PROMs): the Harris Hip Score (HHS), Musculoskeletal Tumor Society Score (MSTS), and the Short Form Survey 36 (SF-36). Furthermore, we performed subgroup analysis in two groups: one divided into survivors and non-survivors, as well as younger individuals (<57 years) and older individuals (>57 years).
    RESULTS: A total of 30 patients were included in the study. At the time of follow-up, 19 patients were deceased. The average duration of follow-up was 3.2 (±2.51) years. The average age at the time of surgery was 60.3 (±15.20) years. Notably, there were no cases of amputation reported (0%). Five cases of implant failure were identified (16.67%). Among these, one was attributed to infection (3.3%), while four resulted from aseptic loosening (13.3%). In terms of functional outcomes, MSTS indicated good results (18 ± 7; range: 7-28; 60%), and the HHS demonstrated moderate outcomes (75.3%). Younger survivors (<57 years) exhibited notably superior results in terms of both the MSTS and physical functioning in the SF-36 (p = 0.03).
    CONCLUSIONS: In summary, this study shows declining tumor arthroplasty-related complications and satisfying functional outcomes as well as QoL. Noteworthy aspects include the relatively low rates of amputation and local tumor recurrences, which significantly favor the selection of appropriate therapeutic options. Moreover, the findings underscore the substantial impact of patients\' age on overall functionality and engagement in daily activities.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    癌症是一种复杂的疾病,也会影响年轻人;然而,它是儿童和青年死亡率相对较高的原因,特别是在低收入和中等收入国家(LMICs)。除此之外,这个年龄段的脂质组学研究很少。因此,我们分析了年轻骨肉瘤(骨肉瘤)患者(12至35岁)的血清样本,并将其脂质组学与对照组样本进行了比较,命名为健康对照(HC组),使用NMR和LC-MS技术。此外,有和没有转移的OS患者之间脂质组学特征的差异表明骨肉瘤中的甘油磷脂胆碱(GPC)和甘油磷脂(GPL)水平较高,胆固醇升高,胆碱,多不饱和脂肪酸(PUFA),转移过程中的甘油。这些差异,在外周血中检测到,可用作液体活检的生物标志物。
    Cancer is a complex disease that can also affect the younger population; however, it is responsible for a relatively high mortality rate of children and youth, especially in low- and middle-income countries (LMICs). Besides that, lipidomic studies in this age range are scarce. Therefore, we analyzed blood serum samples from young patients (12 to 35 years) with bone sarcoma (osteosarcoma) and compared their lipidomics to the ones from the control group of samples, named healthy control (HC group), using NMR and LC-MS techniques. Furthermore, differences in the lipidomic profiles between OS patients with and without metastasis indicate higher glycerophosphocholine (GPC) and glycerophospholipid (GPL) levels in osteosarcoma and increased cholesterol, choline, polyunsaturated fatty acids (PUFAs), and glycerols during the metastasis. These differences, detected in the peripheral blood, could be used as biomarkers for liquid biopsy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:本研究采用了文献计量学方法,以确定过去10年在全球范围内应用3D打印技术治疗骨肿瘤的研究趋势。
    方法:发表于2013年至2022年,与3D打印治疗骨肿瘤相关的论文位于WebofScienceCoreCollection(WoSCC)中,PubMed,还有Scopus.筛选的文章包括在本文献计量学研究中。从WoSCC的这些论文中,关于年度出版物的信息,期刊,关键词,国家,作者,机构,和引用的参考文献被提取并用CiteSpace(6.1版。R6)软件调查使用3D打印治疗骨肿瘤的状态以及研究热点。Carrot2在线可视化工具和Vosviewer软件(版本1.6.20)用于可视化PubMed和Scopus的出版物,分别,以便从两个数据库中确定最受欢迎的研究课题。
    结果:从WoSCC获得了总共606、233和364种出版物,PubMed,还有Scopus,分别,在2013年和2022年之间。在WoSCC中,出版物数量最高的是在2021年,出版了145种出版物。生物杂志(11种出版物)和世界神经外科(10种出版物)是最多产的期刊,生物材料是被引用最多的期刊(244次)。周勇是最有生产力的作者,有14种出版物,而王国全(69次引用)和威廉·F·安内金,(69次引用)引用次数最多。出版物数量最多的国家是中国(207)。在所有机构中,上海交通大学出版的出版物最多(29)。快速原型是引用最强的关键词(4.73)。\'重建\',\'手术\',\'切除\',和“设计”引起了研究人员的极大关注。3D打印材料,骨盆重建术,下颌骨重建,计算机辅助外科技术,光热疗法,体外实验被认为是当前研究的热点和趋势。Scopus中最常见的主题与WoSCC中的主题没有显着差异。PubMed最普遍的研究领域包括植入物,患者特异性,生物陶瓷,模型,和骨盆。
    OBJECTIVE: Bibliometrics was employed in this study to determine the research trends in the worldwide application of 3D printing technology to treat bone tumors over the previous 10 years.
    METHODS: Published from 2013 to 2022, the papers related to bone tumors treated with 3D printing were located in Web of Science Core Collection (WoSCC), PubMed, and Scopus. The screened articles were included in this bibliometric study. From these papers in WoSCC, information on annual publications, journals, keywords, countries, authors, institutions, and cited references were extracted and visualized with CiteSpace (version 6.1.R6) software to investigate the state of bone tumor treatment using 3D printing as well as research hotspots. The Carrot2 online visualization tool and Vosviewer software (version 1.6.20) were employed to visualize the publications from PubMed and Scopus, respectively, in order to ascertain the most popular research topics from both databases.
    RESULTS: A total of 606, 233, and 364 publications were obtained from WoSCC, PubMed, and Scopus, respectively, between the years 2013 and 2022. In WoSCC, the peak number of publications was found in 2021, with 145 publications published. Acta Biomaterialia (11 publications) and World Neurosurgery (10 publications) were the most prolific journals, and Biomaterials was the journal cited the most (244 times). Yong Zhou was the most productive author with 14 publications, while Kwok-Chuen Wong (69 citations) and William F Enneking, (69 citations) possessed the most citations. The country with the largest quantity of publications was China (207). Among all institutions, Shanghai Jiao Tong University produced the most publications (29). Rapid prototyping was the keyword with the strongest citation burst (4.73). \'Reconstruction\', \'surgery\', \'resection\', and \'design\' caught the significant attention of researchers. 3D-printed materials, pelvic reconstruction, mandibular reconstruction, computer-assisted surgical techniques, photothermal therapy, and in vitro experiments were recognized as hot subjects and trends in current research. The most frequently occurring topics in Scopus are not significantly different from those found in WoSCC. The most prevalent research areas in PubMed encompass implant, patient-specific, bioceramic, models, and pelvic.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本研究旨在通过系统综述和荟萃分析总结compress®内置假体(CPS)的生存和并发症情况。
    在线数据库(PubMed,EMBASE和WebofScience)从成立之初到2023年11月进行了搜索。包括在大量节段性骨缺损患者中使用CPS进行假体置换的试验。使用标准化表格提取患者的临床特征和人口统计学数据。纳入的13项非比较研究的方法学质量是根据非随机研究方法学指数(MINORS)进行评估的。使用Engauge-Digitizer软件和用于统计计算的R项目对纳入研究中的所有可用的Kaplan-Meier曲线进行数字化和组合。
    对13项纳入研究的荟萃分析表明:CPS术后全因失败率为26.3%,其中无菌性松动的发生率为5.8%。其他并发症的发生率如下:软组织衰竭(1.8%),结构失效(8.2%),感染(9.5%),肿瘤进展(1.1%)。1-,4-,全因失败的8年总生存率为89%(86%-92%),CI为95%,75%(71%-79%)和65%(60%-70%),分别。全因失败的估计平均生存时间为145个月(95%CI,127-148个月),全因失败的估计中位生存时间为187个月(95%CI,135-198个月).1-,4-,无菌性松动的8年总生存率95%CI为96%(94%-98%),91%(87%-95%)和88%(83%-93%),分别。估计无菌性松动的平均生存时间为148个月(95%CI,137-153个月)。
    CPS的创新弹簧系统通过提供即时和高压缩固定来促进骨骼向内生长,从而降低由应力屏蔽和颗粒诱导的骨溶解引起的无菌性松动的风险。CPS需要较少的残余骨量来重建大量节段性骨缺损,并且由于其非胶结固定而易于翻修。此外,存活率,估计平均生存时间,CPS的并发症发生率并不低于普通内置假体。
    UNASSIGNED: This study aimed to summarize the survival and complication profiles of the compress® endoprosthesis (CPS) through a systematic review and meta-analysis.
    UNASSIGNED: Online databases (PubMed, EMBASE and Web of Science) were searched from inception to November 2023. Trials were included that involved the use of CPS for endoprosthetic replacement in patients with massive segmental bone defects. Patients\' clinical characteristics and demographic data were extracted using a standardized form. The methodological quality of included 13 non-comparative studies was assessed on basis of the Methodological Index for Non-Randomized Studies (MINORS). All the available Kaplan-Meier curves in the included studies were digitized and combined using Engauge-Digitizer software and the R Project for Statistical Computing.
    UNASSIGNED: The meta-analysis of thirteen included studies indicated: the all-cause failure rates of CPS were 26.3 % after surgery, in which the occurrence rates of aseptic loosening were 5.8 %. And the incidences of other complications were as follows: soft tissue failure (1.8 %), structure failure (8.2 %), infection (9.5 %), tumor progression (1.1 %). The 1-, 4-, and 8-year overall survival rates for all-cause failure with 95 % CI were 89 % (86 %-92 %), 75 % (71 %-79 %) and 65 % (60 %-70 %), respectively. The estimated mean survival time of all-cause failure was 145 months (95 % CI, 127-148 months), and the estimated median survival time of all-cause failure was 187 months (95 % CI, 135-198 months). The 1-, 4-, and 8-year overall survival rates of aseptic loosening with 95 % CI were 96 % (94 %-98 %), 91 % (87 %-95 %) and 88 % (83 %-93 %), respectively. The estimated mean survival time of aseptic loosening was 148 months (95 % CI, 137-153 months).
    UNASSIGNED: CPS\'s innovative spring system promotes bone ingrowth by providing immediate and high-compression fixation, thereby reducing the risk of aseptic loosening caused by stress shielding and particle-induced osteolysis. CPS requires less residual bone mass for reconstructing massive segmental bone defects and facilitates easier revision due to its non-cemented fixation. In addition, the survival rate, estimated mean survival time, and complication rates of CPS are not inferior to those of common endoprosthesis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    软骨肉瘤是常见的原发性恶性骨肿瘤;然而,该领域尚未进行全面的文献计量分析。因此,本研究旨在通过文献计量学分析探讨软骨肉瘤领域的研究热点和趋势,帮助研究者了解该领域的研究现状和方向。
    2003年至2022年之间发表的与软骨肉瘤有关的文章和评论从WebofScience检索。国家,机构,作者,期刊,参考文献,使用CtieSpace和VOSviewer软件对该领域的关键词进行了可视化和分析。
    在2003年至2022年之间,发现了4,149篇相关文章。发表关于软骨肉瘤的文章数量每年显著增加,主要来自中国和美国的569家机构,81在其他国家。总的来说,904位作者参与了与软骨肉瘤有关的研究的发表。在过去的20年里,关于软骨肉瘤的文章已在958种学术期刊上发表,骨骼放射学的出版物数量最多。此外,关键词,如“基因表达”,“\”放射治疗,\"\"经验,“凋亡”和“凋亡”近年来一直很流行。
    在过去的20年里,软骨肉瘤研究的全球趋势主要是临床研究,以基础研究为补充。在未来,应加强国家和机构之间的沟通和交流。Further,未来软骨肉瘤领域的主要研究热点包括突变基因和信号通路,精密手术治疗,质子治疗,放射治疗,化疗,免疫疗法,和其他方面。
    UNASSIGNED: Chondrosarcomas are common primary malignant bone tumors; however, comprehensive bibliometric analysis in this field has not yet been conducted. Therefore, this study aimed to explore the research hotspots and trends in the field of chondrosarcoma through bibliometric analysis to help researchers understand the current status and direction of research in the field.
    UNASSIGNED: Articles and reviews related to chondrosarcoma published between 2003 and 2022 were retrieved from the Web of Science. Countries, institutions, authors, journals, references, and keywords in this field were visualized and analyzed using CtieSpace and VOSviewer software.
    UNASSIGNED: Between 2003 and 2022, 4,149 relevant articles were found. The number of articles published on chondrosarcoma has increased significantly annually, mainly from 569 institutions in China and the United States, and 81 in other countries. In total, 904 authors participated in the publication of studies related to chondrosarcomas. Over the past 20 years, articles on chondrosarcoma have been published in 958 academic journals, with Skeletal Radiology having the highest number of publications. Furthermore, keywords such as \"gene expression,\" \"radiotherapy,\" \"experience,\" and \"apoptosis\" have been popular in recent years.
    UNASSIGNED: Over the past 20 years, the global trend in chondrosarcoma research has primarily been clinical research, with basic research as a supplement. In the future, communication and exchange between countries and institutions should be strengthened. Further, the future main research hotspots in the field of chondrosarcoma include mutated genes and signaling pathways, precision surgical treatment, proton therapy, radiation therapy, chemotherapy, immunotherapy, and other aspects.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:为了预防原发性恶性骨肿瘤的保肢手术后感染,重要的是用有足够血流量的肌肉组织覆盖巨型假体。据报道,在切除了股外侧肌和股内侧肌的股骨远端置换病例中,使用腓肠肌外侧皮瓣覆盖;然而,据报道,腓骨神经麻痹的风险很高,因为肌肉皮瓣经过腓骨头附近。进行这项研究是为了检查股骨远端原发性恶性骨肿瘤患者的术后结局,这些患者接受了广泛切除(包括股外侧肌和股内侧肌),然后用巨型假体进行重建并覆盖假体的外侧。缝匠肌皮瓣。
    方法:我们回顾性分析了3例患者,这些患者在广泛切除了股骨远端原发性恶性骨肿瘤,涉及股外侧肌和股内侧肌,并重建了软组织缺损后接受了大型假体重建。
    结果:平均缺损尺寸为6×13厘米,缝匠肌皮瓣所需的平均时间为100分钟,平均植入物覆盖率为93%。术后平均随访35个月,期间无感染等术后并发症,皮肤坏死,或发生神经麻痹。
    结论:远端缝匠肌皮瓣在仰卧位时容易抬高,收获后功能损失最小,神经麻痹的风险极小.可以提倡将其作为覆盖股骨远端外侧软组织缺损的首选方案。
    BACKGROUND: To prevent infection after limb-sparing surgery for primary malignant bone tumors, it is important to cover the megaprosthesis with muscle tissue that has sufficient blood flow. Coverage with a lateral gastrocnemius flap has been reported in cases of distal femoral replacement in which the vastus lateralis and vastus intermedius muscles have been resected; however, the risk of peroneal nerve palsy is reportedly high because the muscle flap passes near the peroneal head. This study was performed to examine the postoperative outcomes of patients with primary malignant bone tumors of the distal femur who underwent wide resection (including the vastus lateralis and vastus intermedius muscles) followed by reconstruction with a megaprosthesis and coverage of the lateral side of the prosthesis with a sartorius muscle flap.
    METHODS: We retrospectively analyzed three patients who underwent reconstruction with a megaprosthesis after wide resection of a primary malignant bone tumor of the distal femur involving the vastus lateralis and vastus intermedius muscles and reconstruction of the soft tissue defect on the lateral side of the prosthesis with a sartorius muscle flap.
    RESULTS: The average defect size was 6 × 13 cm, the average time required for a sartorius muscle flap was 100 min, and the average implant coverage was 93%. The average postoperative follow-up period was 35 months, during which no postoperative complications such as infection, skin necrosis, or nerve palsy occurred.
    CONCLUSIONS: The distally based sartorius muscle flap is easy to elevate in the supine position, has minimal functional loss after harvesting, and has minimal risk of nerve palsy. It can be advocated as the first option for coverage of soft tissue defects lateral to distal femoral replacement.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    由于处理四肢的病理性骨折可能很困难,本研究旨在提出一种治疗下肢骨恶性肿瘤的方法。在金台大学医院骨科共治疗了38例即将发生和病理性骨折的患者。年龄,性别,骨折部位,原发性恶性肿瘤的类型,转移的数量,东部肿瘤协作组骨折前表现状态(ECOG-PS)评分,辅助治疗,治疗方式,手术时间,失血,术后并发症,肌肉骨骼肿瘤协会(MSTS)评分,结果,对原发性恶性肿瘤病例和转移性恶性肿瘤病例的随访时间以及MSTS评分和ECOG-PS进行了比较。比较了髓内钉固定和非髓内钉固定手术中即将发生和病理性骨折的治疗后MSTS评分。疾病部位包括10例患者的股骨转子下,股骨转子8例,股骨干7例,股骨颈5例,双侧股骨转子3例,胫骨近端3例,股骨远端2例。共有10名患者在3-20个部位之间发生转移。骨折前ECOG-PS评分中位数为1.辅助放疗5例,化疗8例,放疗加化疗10例。手术包括18例患者的髓内钉,肿瘤关节置换术4例,钢板固定3例,人工头部置换3例,加压髋螺钉(CHS)3,保守治疗2,双侧髓内钉固定2和人工骨干联合髓内钉和钢板固定,右侧人工头置换和左侧CHS各1例。髓内钉固定的MSTS评分为19.9±8.95,其他术式为24.3±7.45,MSTS评分与骨折前ECOG-PS之间呈负相关。中位随访期为8个月。结果如下:患有疾病,23名患者;持续无病,1名患者;因疾病死亡,14名患者术后1年总生存率为60.5%。此外,转移性恶性肿瘤组,ECOG-PS明显更差,MSTS评分明显低于原发性恶性肿瘤组。作者对下肢恶性骨肿瘤的治疗算法被证明是有用的。
    As managing pathological fractures of the extremities can be difficult, the present study aimed to present a treatment algorithm for lower extremity bone malignancies. A total of 38 patients with impending and pathological fractures were treated at the Department of Orthopedic Surgery in Kindai University Hospital. Age, sex, fracture site, type of primary malignancy, number of metastases, pre-fracture Eastern Cooperative Oncology Group performance status (ECOG-PS) score, adjuvant therapy, treatment modality, operative time, blood loss, postoperative complications, Musculoskeletal Tumor Society (MSTS) score, outcomes, follow-up period and the MSTS scores and ECOG-PS were compared in cases of primary malignant tumors and those cases of metastatic malignant tumors were retrospectively surveyed. Post-treatment MSTS scores in cases of impending and pathological fractures were compared between intramedullary nail fixation and non-intramedullary nail fixation procedures. Disease sites included the sub-trochanteric femur in 10 patients, trochanteric femur in 8, femoral diaphysis in 7, femoral neck in 5, bilateral trochanteric femur in 3, proximal tibia in 3 and distal femur in 2 patients. A total of 10 patients had metastases between 3-20 sites. The median pre-fracture ECOG-PS score was 1. Adjuvant radiotherapy was administered to 5, chemotherapy to 8 and radiotherapy with chemotherapy to 10 patients. Surgical procedures included intramedullary nails in 18 patients, tumor arthroplasty in 4, plate fixation in 3, artificial head replacement in three, compression hip screw (CHS) in 3, conservative treatment in 2, bilateral intramedullary nail fixation in 2 and artificial bone stem with combined intramedullary nail and plate fixation, right-sided artificial head replacement and left-sided CHS in 1 patient each. The MSTS score was 19.9±8.95 for intramedullary nail fixation and 24.3±7.45 for other procedures, with a negative association between the MSTS score and pre-fracture ECOG-PS. The median follow-up period was 8 months. The outcomes were as follows: Alive with disease, 23 patients; continued disease-free, 1 patient; and dead due to disease, 14 patients. The 1-year postoperative overall survival rate was 60.5%. Moreover, the group with metastatic malignant tumors, which had significantly worse ECOG-PS, had significantly lower MSTS scores than the group with primary malignant tumors. The authors\' treatment algorithm for malignant bone tumors of the lower extremity was shown to be useful.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    骨内冬眠瘤是棕色脂肪组织良性肿瘤的罕见表现。影像学鉴别诊断包括骨岛,硬化转移,淋巴瘤血管瘤,和硬化性骨髓瘤.在这份报告中,一名72岁的患者在跌倒后出现右髋部疼痛,导致广泛的诊断工作。骨盆的初始CT无造影提示潜在的硬化转移性疾病。MRI检查结果无法确定。CT引导活检和S-100免疫组织化学染色的进一步评估证实了对骨内冬眠瘤的罕见诊断。此病例描述了罕见的骨内冬眠瘤的多模态成像特征,并讨论了相关良性和恶性骨病变的鉴别诊断考虑因素的成像特征。
    Intraosseous hibernoma is an uncommon presentation of brown adipose tissue benign tumors. Imaging differential diagnoses include bone island, sclerotic metastasis, lymphoma, hemangioma, and sclerotic myeloma. In this report, a 72-year-old patient presented with right hip pain following a fall injury, leading to an extensive diagnostic workup. Initial CT of the pelvis without contrast suggested potential sclerotic metastatic disease. MRI findings could not be definitive. Further assessment with CT-guided biopsy and S-100 immunohistochemical staining confirmed a rare diagnosis of intraosseous hibernoma. This case describes multimodality imaging characteristics of a rare intraosseous hibernoma with discussion of imaging features of differential diagnostic considerations of related benign and malignant bone lesions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号